Medicare Enrolled
Dr. Sisira Reddy
Rheumatology · Atlanta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reddy
Dr. Sisira Reddy is a rheumatology specialist in Atlanta, GA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 4,741 Medicare services across 1,417 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $4,629 from 35 pharmaceutical and/or device companies across 117 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 39% volume in GA
$4,629 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,741
Medicare services
Top 39% in GA for rheumatology
1,417
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~339 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,920 | $18 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
478 | $91 | $213 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
410 | $10 | $50 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
400 | $8 | $30 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
370 | $3 | $20 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
343 | $5 | $39 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
320 | $8 | $20 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
68 | $29 | $110 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
59 | $4 | $22 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
56 | $13 | $60 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
43 | $2 | $18 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
38 | $11 | $45 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
33 | $22 | $67 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $61 | $155 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $105 | $272 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
22 | $38 | $250 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
22 | $6 | $27 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $132 | $334 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
21 | $16 | $55 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
16 | $8 | $35 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
15 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
14 | $69 | $70 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
12 | $10 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,629
Total received (2018-2024)
Avg $661/year across 7 years
Bottom 48% in GA for rheumatology
35
Companies
117
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,774 (59.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,855 (40.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$460
2023
$197
2022
$206
2021
$14
2020
$2,019
2019
$754
2018
$980
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$85
ABBVIE INC.
$82
Medtronic, Inc.
$65
Novartis Pharmaceuticals Corporation
$58
Inspire Medical Systems, Inc.
$57
Radius Health, Inc.
$28
Lundbeck LLC
$25
Corcept Therapeutics
$24
Mannkind Corporation
$19
Exact Sciences Corporation
$17
Top 3 companies account for 50.6% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,295
Janssen Biotech, Inc.
$610
Novartis Pharmaceuticals Corporation
$406
AbbVie, Inc.
$405
Amgen Inc.
$283
ABBVIE INC.
$279
Senseonics, Incorporated
$159
AbbVie Inc.
$159
Lilly USA, LLC
$133
Celgene Corporation
$116
Corcept Therapeutics
$90
Medtronic, Inc.
$65
Mannkind Corporation
$59
Inspire Medical Systems, Inc.
$57
PFIZER INC.
$55
Dynavax Technologies Corporation
$49
Radius Health, Inc.
$45
Dexcom, Inc.
$39
Shire North American Group Inc
$33
Regeneron Healthcare Solutions, Inc.
$29
GlaxoSmithKline, LLC.
$28
Lundbeck LLC
$25
MannKind Corporation
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Horizon Therapeutics plc
$19
Novo Nordisk Inc
$17
Amneal Pharmaceuticals LLC
$17
Exact Sciences Corporation
$17
Orexigen Therapeutics, Inc.
$15
Gilead Sciences, Inc.
$15
Bausch Health US, LLC
$14
West-Ward Pharmaceuticals
$14
SANOFI PASTEUR INC.
$14
Nalpropion Pharmaceuticals LLC
$12
AstraZeneca Pharmaceuticals LP
$11
Top 3 companies account for 49.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AMJEVITA · Aimovig · CONTRAVE · COSENTYX · CYLTEZO · Cologuard Collection Kit · Dexcom G6 Transmitter · EVENITY · Enbrel · Eversense · FARXIGA · FLUZONE QUADRIVALENT · FORTEO · HUMIRA · Heplisav-B · Humira · INSPIRE · KRYSTEXXA · Korlym · LYRICA · MINIMED 780G · Mitigare · NATPARA (PARATHYROID HORMONE) · Otezla · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · RINVOQ · Repatha · Rinvoq · SHINGRIX · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · Tymlos · UNITHROID · VYEPTI · WELLBUTRIN XL · Wegovy · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
87
Per 100K population
8.1
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Reddy performed 1,920 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $4,629 from 35 companies across 117 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other rheumatologists in Atlanta?
Dr. Reddy's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Atlanta
Browse rheumatologists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in GA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in GA
Which GA rheumatologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology